VanEck Biotech ETF (NASDAQ:BBH) & Mexico Equity & Income Fund (NYSE:MXE) Head-To-Head Comparison

Mexico Equity & Income Fund (NYSE:MXE) and VanEck Biotech ETF (NASDAQ:BBH) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability.

Dividends

Mexico Equity & Income Fund pays an annual dividend of $0.30 per share and has a dividend yield of 3.4%. VanEck Biotech ETF pays an annual dividend of $1.25 per share and has a dividend yield of 0.8%.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Mexico Equity & Income Fund and VanEck Biotech ETF, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mexico Equity & Income Fund	0	0	0	0	0.00
VanEck Biotech ETF	0	7	3	0	2.67

VanEck Biotech ETF has a consensus price target of $161.06, suggesting a potential upside of 0.00%. Given VanEck Biotech ETF’s stronger consensus rating and higher possible upside, analysts clearly believe VanEck Biotech ETF is more favorable than Mexico Equity & Income Fund.

Insider and Institutional Ownership

32.0% of VanEck Biotech ETF shares are held by institutional investors. 6.1% of Mexico Equity & Income Fund shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Mexico Equity & Income Fund has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, VanEck Biotech ETF has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

Profitability

This table compares Mexico Equity & Income Fund and VanEck Biotech ETF’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mexico Equity & Income Fund	N/A	N/A	N/A
VanEck Biotech ETF	N/A	N/A	N/A

Earnings & Valuation

This table compares Mexico Equity & Income Fund and VanEck Biotech ETF”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mexico Equity & Income Fund	-$6.05 million	-6.32	N/A	N/A	N/A
VanEck Biotech ETF	N/A	N/A	N/A	N/A	N/A

Summary

VanEck Biotech ETF beats Mexico Equity & Income Fund on 5 of the 8 factors compared between the two stocks.

About Mexico Equity & Income Fund

Mexico Equity & Income Fund Inc. is a closed ended balanced mutual fund launched and managed by Pichardo Asset Management, S.A. de C.V. The fund invests in the fixed income and public equity markets of Mexico. It also invests some portion in the convertible securities. The fund invests in the stocks of companies operating across diversified sectors. It benchmarks the performance of its portfolio against the Mexbol and MSCI Mexico Index. Mexico Equity & Income Fund Inc. was formed on May 24, 1990 and is domiciled in the United States.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.